ERDRP-0519

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameERDRP-0519
Drug Alias NameERDRP-0519
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRNA-directed RNA polymerase inhibitors
TargetsRNA-directed RNA polymerase
Therapy Area/IndicationsMeasles
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPaul Ehrlich Institute Langen
China Registration ClassN/A

Develop Information

Active CompaniesPaul Ehrlich Institute Langen
Inactive CompaniesN/A
Active IndicationsMeasles
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A